Invention Application
- Patent Title: MINIMALLY INVASIVE IMPLANTABLE NEUROSTIMULATION SYSTEM
-
Application No.: US16947944Application Date: 2020-08-25
-
Publication No.: US20200376255A1Publication Date: 2020-12-03
- Inventor: Brad C. Tischendorf , John E. Kast , Thomas P. Miltich , Gordon O. Munns , Randy S. Roles , Craig L. Schmidt , Joseph J. Viavattine , Christian S. Nielsen , Prabhakar A. Tamirisa , Anthony M. Chasensky , Markus W. Reiterer , Chris J. Paidosh , Reginald D. Robinson , Bernard Q. Li , Erik R. Scott , Phillip C. Falkner , Xuan K. Wei , Eric H. Bonde , David A. Dinsmoor , Duane L. Bourget , Forrest C M Pape , Gabriela C. Molnar , Joel A. Anderson , Michael J. Ebert , Richard T. Stone , Shawn C. Kelley , Stephen J. Roddy , Timothy J. Denison , Todd V. Smith
- Applicant: Medtronic, Inc.
- Main IPC: A61N1/02
- IPC: A61N1/02 ; A61B17/00 ; A61N1/05 ; A61N1/372 ; A61N1/375 ; A61N1/36 ; A61N1/378

Abstract:
A neuromodulation therapy is delivered via at least one electrode implanted subcutaneously and superficially to a fascia layer superficial to a nerve of a patient. In one example, an implantable medical device is deployed along a superficial surface of a deep fascia tissue layer superficial to a nerve of a patient. Electrical stimulation energy is delivered to the nerve through the deep fascia tissue layer via implantable medical device electrodes.
Public/Granted literature
- US11957893B2 Minimally invasive implantable neurostimulation system Public/Granted day:2024-04-16
Information query